University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.
Features
Evolution of urinalysis: the journey from dipstick to digital solution
Julie Elston provides an insight into the evolution of urinalysis. She argues that digital solutions could address some of the issues associated with urinalysis – such as improper handling, inconsistent dip times, subjective interpretation, and inefficient processes.
Early-onset colorectal cancer: an increasing healthcare issue
Historically, colorectal cancer was seen as a disease of later life. More recently, however, the increased incidence of cancer affecting the lower intestinal tract in the younger age group has been reported. Here, Pathology in Practice Science Editor Brian Nation looks at a selection of current research focusing on this emerging healthcare...
Products
ProtonDx's Dragonfly evaluated for identifying hidden malaria cases
A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.
New blood-based assay for Alzheimer's disease research
Precision proteomics firm Alamar Biosciences has announced the launch of the NULISAqpcr BD-pTau217 Assay, which it says is a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal biomarker in Alzheimer's disease research and other tauopathies.
Ten-colour PCR platform bridges gap between PCR and NGS
Countable Labs has announced the launch of Countable 10, the first and only PCR platform capable of 10-color multiplexing. The new platform will extend the utility of the company’s core Countable PCR technology to enable higher level multiplexing that easily and cleanly reveals more insights in a single reaction.
Gestalt launches PathFlow update
Gestalt has announced the release of PathFlow Version 6, the latest evolution of its award-winning digital pathology platform.
Latest Issues
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
BDIAP Molecular Pathology Study Day
10 Union Street, London, SE1 1SZ
2 March, 2026
UK NEQAS webinar: Introduction to Cellular Components, Tissue Morphology and Tissue Recognition
Online
3-4 March, 2026
Cell & Gene Therapy 2026
Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026
UK NEQAS webinar: Specialist Demonstration of Lipids, Pigments, Minerals, and Infections
Online
10-11 March, 2026
USCAP 115th Annual Meeting
Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026